Boyraz Gokhan, Başaran Derman, Salman Mehmet C, Özgül Nejat, Yüce Kunter
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hacettepe University School of Medicine, Ankara, Turkey.
Balkan Med J. 2016 Nov;33(6):657-661. doi: 10.5152/balkanmedj.2016.151232. Epub 2016 Nov 1.
In women with endometrial hyperplasia, there is a risk for co-existent endometrial cancer when patients are subjected to immediate surgical treatment.
The aim of this study was to investigate the frequency of endometrial cancer and the accuracy of frozen section analysis at the time of hysterectomy among patients with endometrial hyperplasia, to reveal whether or not a preoperative diagnosis of endometrial hyperplasia necessitates frozen section consultation.
Retrospective cross-sectional study.
A department database review was performed to identify patients who were subjected to hysterectomy with a preoperative diagnosis of endometrial hyperplasia, during the period from 2007 to 2014.
The study group included 189 cases. The final pathological examination revealed endometrial cancer in 16 women (8.4%). The risk of cancer in patients with endometrial hyperplasia was 1 of 125 (0.8%) in simple hyperplasia without atypia, 1 of 21 (4.8%) in complex hyperplasia without atypia and 14 of 43 (32.5%) in atypical hyperplasia. Of women with cancer, 2 of 16 (12.5%) had high-risk features. Frozen section analysis was requested in 46 cases. Frozen sections helped to identify six out of 11 cases of endometrial cancer (54.5%). The sensitivity, specificity and positive and negative predictive values of frozen section analysis for the detection of endometrial cancer among women with endometrial hyperplasia were 54.4%, 97.2%, 85.7% and 87.5%, respectively.
Although a significant proportion of patients with atypical endometrial hyperplasia are diagnosed with endometrial cancer following hysterectomy, most of these cases have low-risk features and do not require surgical staging. Additionally, intraoperative frozen section analysis if not helpful for diagnosing concurrent endometrial cancer in patients with endometrial hyperplasia. Therefore, it seems that patients with endometrial hyperplasia can be operated upon in settings with no available method for obtaining frozen sections intraoperatively.
对于子宫内膜增生的女性患者,若接受即刻手术治疗,存在同时合并子宫内膜癌的风险。
本研究旨在调查子宫内膜增生患者子宫切除时子宫内膜癌的发生率以及冰冻切片分析的准确性,以揭示术前诊断为子宫内膜增生是否需要进行冰冻切片会诊。
回顾性横断面研究。
对科室数据库进行回顾,以确定2007年至2014年期间术前诊断为子宫内膜增生并接受子宫切除术的患者。
研究组包括189例患者。最终病理检查显示16例女性(8.4%)患有子宫内膜癌。子宫内膜单纯性增生不伴不典型增生的患者中,癌症风险为125例中的1例(0.8%);复杂性增生不伴不典型增生的患者中,癌症风险为21例中的1例(4.8%);不典型增生的患者中,癌症风险为43例中的14例(32.5%)。患癌女性中,16例中有2例(12.5%)具有高危特征。46例患者进行了冰冻切片分析。冰冻切片有助于识别11例子宫内膜癌中的6例(54.5%)。在子宫内膜增生女性中,冰冻切片分析检测子宫内膜癌的敏感性、特异性及阳性和阴性预测值分别为54.4%、97.2%、85.7%和87.5%。
尽管相当一部分不典型子宫内膜增生患者在子宫切除术后被诊断为子宫内膜癌,但这些病例大多具有低危特征,不需要手术分期。此外,术中冰冻切片分析对诊断子宫内膜增生患者并发的子宫内膜癌并无帮助。因此,对于子宫内膜增生患者,似乎可以在术中无法获得冰冻切片的情况下进行手术。